Healthcare Equipment and Supplies
Company Overview of Amedica Corporation
Amedica Corporation engages in the manufacture and distribution of spine and reconstructive surgery implants and instruments using silicon nitride ceramic technologies. Its products include cervical spacers, lumbar spacers, cervical plate systems, concise anterior cervical plate systems, pedicle screw systems, and synthetic bone putties. The company also offers amniotio-derived tissue products, including structural tissue matrix products and resorbable adhesion barriers. In addition, it offers spine products, such as facet fixation systems, MIS locking facet systems, posterior lumbar PLIF/TLIF spacers, spine systems, complex spine systems, and bone graft substitutes. Further, the company dis...
1885 West 2100 South
Salt Lake City, UT 84119
Founded in 1996
Key Executives for Amedica Corporation
Senior Vice President of Market Development
Compensation as of Fiscal Year 2012.
Amedica Corporation Key Developments
Amedica Corporation Implements 10,000th Worldwide Implantation of its Valeo Interbody Fusion Devices
Mar 22 13
Amedica Corporation announced the 10,000(th) worldwide implantation of its Valeo Interbody Fusion Devices. The Valeo Interbody Fusion Device System, made of Amedica's proprietary Silicon Nitride ceramic technology, is used during surgical procedures to treat spinal disorders such as spondylolisthesis, scoliosis, severe disc degeneration, or spinal fractures.
Amedica Corporation Appoints Karl Farnsworth as Chief Financial Officer
Mar 11 13
Amedica Corporation announced that Karl Farnsworth has been named Chief Financial Officer (CFO) on February 21, 2013. Mr. Farnsworth brings more than 25 years of experience as a financial executive for growth-oriented, publicly traded companies in multiple industries. He most recently served as the Senior Vice President and Treasurer with Energy Solutions Inc. where he led working capital initiatives generating more than $30 million of sustainable cash. Prior to joining Amedica, Mr. Farnsworth served as CFO for Alcan Products Corporation, part of Alcan Inc., which was acquired by Rio Tinto Corporation in 2007. While at Alcan Inc. he spearheaded significant capital investments for the expansion of Alcan's global reach in manufacturing and market penetration into China and Mexico. Also during his tenure at Alcan, he directed a $200 million cash generation initiative throughout Europe and North America. Additionally, Mr. Farnsworth was appointed and served as a Director on the following corporate boards: Alcan Cable (Canada) Inc.; Stabiloy De (Mexico); EPA Holdings Ltd. (Hong Kong); APC Holding Corporation (USA); and, Alcan (Tianjin) Alloy Products Corporation (China).
Amedica Corporation Expands Patent Portfolio with Proprietary Silicon Nitride Total Disc Implant to Treat Neck and Back Pain
Feb 28 13
Amedica Corporation announced that the company received a new patent for an artificial spinal disc implant based on its proprietary Silicon Nitride (Si(3) N(4)) ceramic material. Amedica's artificial spinal disc implant is unique in its design, material and construction. This is a distinct differentiation from existing metal-on-plastic or metal-on-metal designs. By leveraging Silicon Nitride, Amedica's artificial spine disc implant has the potential to provide patients with increased longevity of the implant due to lower wear, better osteointegration and reduced infection rates.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|